The FDA has approved the first hemodynamic support device from AbioMed.  The Impella 2.5 System has gained “premarket approval for use during high risk PCI procedures” according to an article via  The blood pump will be a temporary device for patients with severe symptomatic coronary artery disease and diminished heart function.  For more information on this new device approval, please visit: